- FDA panel recommends mRNA flu vaccine for older adults The Hill —
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News —
- Experimental treatment for pancreatic cancer could be breakthrough for patients NBC News —
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR —
- FDA advisors unanimously vote to approve Moderna's mRNA after agency drama Ars Technica —
- Pancreatic cancer mRNA vaccine shows lasting results in an early trial NBC News —
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology PBS —
RNA vaccine
Vaccine that transfects synthetic RNA, reprogramming cells to make foreign protein that stimulates an adaptive immune response
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells. The mRNA is delivered by a co-formulation of the RNA encapsulated in lipid nanoparticles that protect the RNA strands and help their absorption into the cells.
Also known as...
mRNA vaccine, mRNA-based vaccine, messenger RNA vaccine, mRNA vaccines, and RNA vaccines
FDA Panel Backs Moderna mRNA Flu Shot
An FDA advisory panel unanimously recommended the approval of Moderna's mRNA-based flu vaccine for older adults, a major milestone for the platform beyond COVID-19.